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A B S T R A C T   
Here we report the molecular networks associated with the mucosal and systemic responses to peracetic acid 
(PAA), a candidate oxidative chemotherapeutic in Atlantic salmon (Salmo salar). Smolts were exposed to 
different therapeutic doses (0, 0.6 and 2.4 mg/L) of PAA for 5 min, followed by a re-exposure to the same 
concentrations for 30 min 2 weeks later. PAA-exposed groups have higher external welfare score alterations, 
especially 2 weeks after the re-exposure. Cases of fin damage and scale loss were prevalent in the PAA-exposed 
groups. Transcriptomic profiling of mucosal tissues revealed that the skin had 12.5 % more differentially 
regulated genes (DEGs) than the gills following PAA exposure. The largest cluster of DEGs, both in the skin and 
gills, were involved in tissue extracellular matrix and metabolism. There were 22 DEGs common to both mucosal 
tissues, which were represented primarily by genes involved in the biophysical integrity of the mucosal barrier, 
including cadherin, collagen I α 2 chain, mucin-2 and spondin 1a. The absence of significant clustering in the 
plasma metabolomes amongst the three treatment groups indicates that PAA treatment did not induce any global 
metabolomic disturbances. Nonetheless, five metabolites with known functions during oxidative stress were 
remarkably affected by PAA treatments such as citrulline, histidine, tryptophan, methionine and trans-4- 
hydroxyproline. Collectively, these results indicate that salmon were able to mount mucosal and systemic 
adaptive responses to therapeutic doses of PAA and that the molecules identified are potential markers for 
assessing the health and welfare consequences of oxidant exposure.   
1. Introduction 
Chemotherapeutics are still used to treat fish diseases, however, 
stricter rules for their application have been implemented in different 
aquaculture-producing countries and many have shifted to more envi-
ronmentally friendly options (Buchmann, 2015; Burridge et al., 2010; 
Quesada et al., 2013). Nonetheless, chemotherapeutics remain the only 
available alternatives in some cases (Holan et al., 2017; Overton et al., 
2019). There are persistent apprehensions regarding the use of chemical 
disinfectants for disease treatment, especially against ectoparasitic in-
fections, which may be partly related to their excessive use and the lack 
of experimentally verified data on how they impact the fish and the 
environment. The use of hydrogen peroxide (H2O2) in Atlantic salmon 
farming is a good example (Bechmann et al., 2019; Hjeltnes et al., 2019). 
It is imperative that an integrative approach is adopted for streamlining 
the use of chemicals (e.g., parasiticides) in aquaculture (Pedersen et al., 
2009). 
Peracetic acid (CH3CO3H, hereafter referred to as PAA) is a potent 
oxidative organic compound that has gained prominence in the last ten 
years as a sustainable disinfectant in aquaculture (Gesto et al., 2018; 
Pedersen et al., 2013). It is the peroxide of acetic acid and is commer-
cially available in an equilibrium mixture with acetic acid, H2O2 and 
water. PAA has high oxidising potential and fat solubility (Luukkonen 
and Pehkonen, 2017), in which both properties are contributory to its 
broad potency against numerous fish pathogens including Ichthyoph-
thirius multifiliis, Aeromonas salmonicida, Flavobacterium columnare, Yer-
sinia ruckeri, Saprolegnia spp., Aphanomyces spp., and infectious salmon 
anaemia virus (Meinelt et al., 2015; Straus et al., 2018a). The antimi-
crobial activity of PAA is based on the formation of highly reactive free 
radicals and the release of active oxygen atoms that eventually disrupt 
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the chemiosmotic function of the lipoprotein cytoplasmic membrane 
and transport through the dislocation or rupture of cell walls (Kitis, 
2004; Straus et al., 2012a). PAA has stronger disinfecting power than 
H2O2 because of the former’s fat solubility (Block, 1991). The combi-
nation of PAA and H2O2 is synergistic (Alasri et al., 1992). 
While earlier studies documented the potency of PAA against 
numerous pathogens and toxicity towards a number of farmed fish 
species (Straus et al., 2012a, b; Straus et al., 2018a), there is a major gap 
in our understanding of the physiology behind the adaptations of fish to 
this strong oxidant. This is a crucial aspect that must be addressed in 
order to fully substantiate the claim that PAA is a more eco-friendly and 
safe alternative peroxide for fish. As an oxidative disinfectant with free 
radicals and reactive oxygen as intermediate products, PAA may trigger 
oxidative stress. In both rainbow trout and Atlantic salmon (Salmo 
salar), singular and repeated exposure to PAA could trigger oxidative 
stress as indicated by an increase in systemic antioxidant levels, as well 
as in other stress-related indicators such as cortisol and glucose (Liu 
et al., 2020; Soleng et al., 2019). Nevertheless, the recovery was quick 
and there was no lasting impact, demonstrating that the changes 
observed were likely physiological adaptations to the therapeutic doses 
of PAA (Gesto et al., 2018; Liu et al., 2017a, b). However, the extent to 
which PAA impacts fish physiology remains unknown. To our knowl-
edge, no global response study has been conducted in fish exposed to 
PAA. Elucidating the physiological response at the molecular level will 
provide a better understanding of the biological mechanisms of PAA and 
identify markers that may be valuable for health monitoring following 
oxidant treatment. 
Here we investigated the health and welfare impact of exposing 
salmon smolts to therapeutic doses of PAA. This oxidant is currently 
being explored as a chemotherapeutic for amoebic gill disease (AGD) in 
salmon. There are no available data on the tolerance of salmon to PAA, 
therefore, we identified the test concentrations used in this study based 
on their earlier applications against key fish pathogens (Straus et al., 
2018b), reported in another salmonid species (rainbow trout) (Davidson 
et al., 2019; Hushangi and Hosseini Shekarabi, 2018; Liu et al., 2020), 
and biocidal activity against Neoparamoeba perurans, the causative agent 
of AGD (Breiland et al., 2019). An ideal chemotherapeutic in aquacul-
ture should be effective against the pathogen, have minimal environ-
mental risk and not pose substantial health and welfare issues to the fish 
(Pedersen and Lazado, 2020). The first two characteristics have been 
explored to some extent with regards to the application of chemical 
disinfectants in aquaculture, whereas our knowledge on the third 
feature is fragmentary. This manuscript addresses this knowledge gap by 
employing global transcriptomic and metabolomic profiling techniques. 
2. Materials and methods 
2.1. Ethics statement 
All fish handling procedures employed in this study were in accor-
dance with national and EU legislation (2010/63/EU) on animal 
experimentation. 
2.2. Fish and husbandry conditions 
The experimental fish were sourced from a local land-based RAS 
supplier (Danish Salmon, Hirtshals, Denmark) and transported to the 
experimental recirculation aquaculture facility of DTU Aqua (Hirtshals, 
Denmark). The fish had not been exposed to any oxidant prior to this 
trial. Sixty fish (~ 100 g) were stocked in each of the 6 1-m2 holding 
tanks (volume approximately 600 L) connected to a common recircu-
lation system with seawater (33–34 ppt) at 15 ± 1 ◦C. Details of the RAS 
and other system parameters are described in a previous publication 
(Soleng et al., 2019). The experimental hall was illuminated following a 
16L:8D (0600-2200) photoperiod cycle. Regular production feed (Bio-
mar, EFICO Enviro, 4.5 mm, Brande, Denmark) was provided via a belt 
feeder at a provision of 1–1.5 % total biomass per day. The experimental 
fish were allowed to acclimate to the experimental conditions for 3 
weeks. 
2.3. Exposure to therapeutic doses of peracetic acid (PAA) 
Feeding was temporarily ceased 24 h prior to PAA exposure. The 
exposure protocol is described in detail in an earlier publication (Soleng 
et al., 2019). Briefly, fish were netted out from the holding tank and 
immediately transferred to an exposure tank with similar volume and 
water quality parameters. Thereafter, fish were exposed to three nomi-
nal doses of PAA (Divosan® Forte, Lilleborg AS, Oslo, Norway): 0 (con-
trol), 0.6 and 2.4 mg/L. The actual PAA concentration in the trade 
product (ca 18 % PAA) and its degradation during the trial had been 
experimentally verified and previously reported (Pedersen and Lazado, 
2020). Two replicate tanks were allocated for each treatment group. 
After 5 min, the fish were immediately netted out of the PAA-exposure 
tanks and returned to their respective holding tanks. Following a 
two-week recovery from the initial exposure, the fish were re-exposed to 
the same concentration of PAA using the same protocol as in the initial 
exposure, except that the duration lasted for 30 min. The fish were then 
allowed to recover for 2 weeks. The experiment was designed to reduce 
the number of fish used in a trial involving live animals but still robust to 
answer key questions on how salmon respond to singular exposure and 
re-exposure of PAA. This adheres to the 3R (reduce, reuse, replace) 
principles in aquaculture research. 
The choice for the age and size of fish in the trial was based on the 
eventual application of PAA, i.e. as a treatment for AGD. This disease 
affects salmon in the saltwater stage and the treatment (i.e. H2O2 or 
freshwater) is usually performed when the fish are between 100− 500 g. 
The exposure protocol simulated a proposed method of treating AGD at 
an early stage (0.5–1 gill score) which requires a short contact time with 
the fast-acting, potent PAA oxidant, but when the disease further de-
velops, a treatment at a longer duration is to be administered. The 30- 
min exposure time is a common exposure time in treating AGD infec-
ted fish (Hytterød et al., 2017). 
2.4. Sample collection 
Sample collection was performed at 48 h and 2 weeks after each 
exposure occasion. The results at 2 weeks post-exposure provided in-
sights into the persistent consequences of the treatment. Five fish were 
taken from each replicate tank and were humanely euthanised with an 
overdose of benzocaine solution (n = 10 per group). After the length and 
weight of the fish were determined, the external welfare status was 
evaluated according to the FISHWELL handbook (Noble et al., 2018). 
The welfare scoring scheme includes 11 external welfare parameters 
(emaciation, eye damage, skin damage, operculum damage, snout 
damage, vertebral deformity, jaw deformity, dorsal fin damage, caudal 
fin damage, pectoral fin damage and pelvic fin damage) that are scored 
0–3, with 0 as fully intact and 3 as severely compromised. To ensure 
objectivity and limit biases, only one person, who did not have prior 
knowledge about the treatments, evaluated all the fish throughout the 
experiment. Blood was withdrawn from the caudal artery using a hep-
arinised vacutainer, centrifuged at 1000 x g for 10 min at 4 ◦C, plasma 
was collected and kept at − 80 ◦C until analysis. Small portions of the 
dorsal skin and the second gill arch were collected, suspended in RNA-
later™ (Thermo Fischer Scientific, City, MA, USA) incubated for over-
night penetration at room temperature and stored at − 80 ◦C until RNA 
isolation. 
2.5. RNA extraction and microarray analysis 
Total RNA was isolated from the skin and gill tissues using Agencourt 
RNAdvance™ Tissue Total RNA Purification Kit (Beckman Coulter Inc., 
CA, USA). The RNA concentration was determined using a NanoDrop 
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8000 spectrophotometer (Thermo Fischer Scientific) and the quality was 
further assessed with the Agilent® 2100 Bioanalyzer™ RNA 6000 Nano 
Kit (Agilent Technology Inc., Santa Clara, CA, USA). All samples had an 
RNA Integrity Number (RIN) above 9. Nofima’s Atlantic salmon DNA 
oligonucleotide microarray SIQ-6 (custom design, GPL16555) contains 
15 K probes for protein-coding genes involved in immunity, tissue 
structure, integrity and function, cell communication and junctions and 
extracellular matrix, among many others (Krasnov et al., 2011). Anno-
tation of this microarray contains four major groups: Tissue, which in-
cludes genes with known functions in tissue structure, integrity, 
development and architecture; Metabolism, which includes genes with 
known functions in metabolic processes; Immune, which includes genes 
with known functions in innate and adaptive, cellular and humoral 
immune responses; Cell, which includes genes with known functions in 
cellular processes, development, communication and signalling. Agilent 
Technologies manufactured and supplied the microarrays, reagents and 
equipment used in the analysis. RNA amplification and Cy3 labelling 
were performed with the One-Color Quick Amp Labelling Kit with a 
200-ng RNA template per reaction and Gene Expression Hybridization 
Kits were used for the fragmentation of labelled RNA. Hybridisation was 
carried out for 17 h in an oven at 65 ◦C with a constant rotation speed of 
10 rpm. Thereafter, the arrays were washed successively with Gene 
Expression Wash Buffers 1 and 2 and were scanned using the Agilent 
SureScan Microarray Scanner. Data processing was carried out in Nofi-
ma’s bioinformatics package STARS. 
2.6. Plasma metabolomics 
Plasma samples were reconstituted in 200 μL Eluent A and trans-
ferred to an HPLC vial. The analysis was carried out using a UPLC system 
(Vanquish, Thermo Fisher Scientific) coupled with a high-resolution 
quadrupole-orbitrap mass spectrometer (Q Exactive™ HF Hybrid 
Quadrupole-Orbitrap, Thermo Fisher Scientific). An electrospray ion-
isation interface was used as the ionisation source. The analysis was 
performed in negative and positive ionisation modes. The UPLC was 
performed using a slightly modified version of the protocol described by 
Doneanu et al. (Doneanu et al., 2011). Data-processing was carried out 
in MZmine 2 (Pluskal et al., 2010) followed by curation using a custom 
made in-house protocol of MS-Omics ApS (Denmark). Identification of 
compounds was performed using both peak retention times (compared 
against authentic standards included in the analytical sequence) and 
accurate mass (with an accepted deviation of 0.0005 Da). This targeted 
approach was used to extract the response of compounds included in the 
in-house standard list of MS-Omics ApS, covering 142 compounds. The 
relative concentrations are peak areas normalised using linear regres-
sion of the signal in QC samples to remove systematic variation 
throughout the sequence. 
Compound identification was performed in two levels: level one 
included compounds identified based on accurate mass and retention 
times matched with those from authentic standards analysed in MS- 
Omics ApS laboratory, whereas level two was based on accurate mass 
and estimated retention times as inferred from the structural informa-
tion of the compound. Compounds identified in level two are indicated 
with a question mark in front of their name. 
2.7. Data handling 
The overall welfare index was calculated by averaging the combined 
scores from the different welfare parameters. One-way ANOVA was used 
to identify inter-treatment differences for a welfare index and statistical 
significance was set at p < 0.5. 
Microarray expression values were log2 transformed and further 
processed in R (version 3.5.2, https://www.r-project.org/). The values 
were normalised to the expression values of the control group and 
ANOVAs were calculated for each gene to identify significant differences 
between treatments and time points (package HybridMTest). Mean 
expression values for each group (treatment and time point) were 
calculated and the absolute difference between minimum and maximum 
was determined for each gene. Differentially expressed genes (DEGs) 
were defined as genes with a minimum absolute difference of 0.5 and a 
significant difference in the ANOVAs (p < 0.05). Groupwise mean DEGs 
were clustered according to their Euclidean distance with the complete 
linkage method (function hclust from package stats). The resulting 
dendrogram was cut into sub-clusters to achieve a sufficient separation 
without too much fragmentation (function cutree package stats). 
Dendrogram and group means were plotted with the function heatmap.2 
(package gplots). Mean values by group within the sub-clusters were 
plotted in custom bar graphs with the respective standard error of the 
mean added as +/- error bars. The STARS package provides a categorical 
annotation of gene functions, which is based on public gene annotations 
and experience from previous experiments. At the time of this analysis, 
106 different categories were present on the used 15k microarray and 
approximately two-thirds of the represented genes were annotated with 
these categories. Functional gene categories were counted for each sub- 
cluster and enrichment analyses were computed using Fisher’s exact test 
(function fisher.test). Results were filtered for at least one significantly 
enriched (p < 0.05) category within the sub-clusters and plotted as dots 
of different sizes, with bigger dots for lower p-values. 
A PCA model of the plasma metabolome was generated using the 
reduced dataset. The change in metabolite concentration in the PAA- 
exposed groups (0.6 and 2.4 mg/L) was expressed as log2 ratio or the 
logarithmic value of the fold change relative to the control group (0 mg/ 
L) at a specific time-point. The statistical change between two groups 
was determined by t-test. A compound regarded as a differentially 
modulated metabolite should pass the following condition: P < 0.05, 
log2 ratio > 0.3. 
3. Results and discussion 
3.1. PAA exposure does not elicit aberrant behavioural responses 
PAA is recognised as a strong irritant and lacrimator in mice 
(Gagnaire et al., 2002), and, as such, may trigger sensory irritation. The 
narratives from earlier studies in rainbow trout suggest that erratic 
swimming, agitation and gasping for air are some of the typical 
behavioural responses observed following PAA exposure at concentra-
tions from 0.5 to 2 mg/L. These are fundamental responses associated 
with sentient organisms’ processing of a potential threat in their im-
mediate environment. The present study observed no major behavioural 
changes in the experimental fish during the first exposure and the 
re-exposure trials, as well as during recovery. The fish remained calm 
and exhibited no apparent agitation during both exposure occasions. 
This suggests that the therapeutic doses of PAA used were not identified 
by the fish as a potential danger, hence, no escape behaviour was 
observed, though we cannot exclude the potential limitation of space in 
the tank. This was further supported by the zero-mortality record 
throughout the trial. The fish resumed feeding right after each treatment 
in all exposure trials. Weight at termination was not statistically 
different amongst treatment groups. Unaltered production performance 
after treatment corroborated earlier observations in rainbow trout 
(Hushangi and Hosseini Shekarabi, 2018; Liu et al., 2017b), indicating 
that the treatment did not interfere with the growth potential and 
metabolism of salmon, as supported in part by the metabolomics data 
(discussed in Section 3.4). 
3.2. External welfare scores remain favourable after oxidant exposure 
External welfare parameters are operative indices that may be used 
on farms as indications of the welfare status of salmon (Noble et al., 
2018). Using semi-quantitative scoring, this rough evaluation can help 
farm operators gauge the impact of husbandry practices, for example, 
stocking density, handling and treatment, to name a few. We applied this 
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strategy in the present experiment to determine whether a simulated 
PAA treatment could affect the external welfare of smolts. Overall, 
oxidant exposure did not significantly affect the overall external welfare 
status of salmon (Fig. 1A), with composite scores below 1, on a scale of 
0–3. 
We further evaluated variations in the individual 11 external pa-
rameters in the scoring scheme (Fig. 1B,C). At 2 weeks post-exposure, 
the profile was similar on both occasions, though it was quite 
apparent that the scores were relatively lower after the re-exposure 
compared with the first exposure. Skin, pectoral fin, and dorsal fin 
damage amongst the parameters were considerably represented in both 
exposure trials and in all three treatment groups. Almost 90 % of the 
recorded skin damage was scale loss. This may be attributed to the 
handling and transfer of the fish from the holding to the exposure tank. 
The alterations in all the evaluated parameters in oxidant-exposed 
groups were not statistically different from the control. These results 
show that PAA at the tested concentrations did not compromise the 
external welfare of salmon. Moreover, re-exposure to the same dose at 
longer durations did not aggravate previously highly scored external 
parameters (i.e., fin and skin damages). 
3.3. Oxidant exposure orchestrates a network of adaptive responses at the 
mucosal surfaces 
Mucosal surfaces (i.e., skin, gills, gut, olfactory) are the interface 
between the fish and the surrounding aquatic environment and, hence, 
encounter constant stringent biological pressures (Cabillon and Lazado, 
2019). One of these is the changing levels of environmental reactive 
oxygen species (ROS), which greatly impact the organism’s key bio-
logical processes. In aquaculture, fish are often exposed to higher levels 
of environmental ROS using strong oxidative disinfectants either as a 
treatment for ectoparasitic infection or routine treatment of rearing 
water. 
Global transcriptomic profiling revealed that there were 587 differ-
entially expressed genes (DEG) in the gills following exposure to the 
oxidative disinfectant (Fig. 2). The full list of DEGs is provided in Sup-
plementary File 1. We further subdivided these DEGs into 7 clusters based 
on their expression profiles. Cluster 1 represents the largest group with 
329 DEGs, though the overall magnitude of response was lower compared 
with the other clusters (i.e., Clusters 3, 4, 5 and 6) (Fig. 2A). About 25 % of 
the DEGs in Cluster 1 are involved in mucosal tissue adhesion, differen-
tiation, extracellular matrix and neural activity (Fig. 2B). In both PAA- 
exposed groups, the collective tendency was downregulation at 48 h 
after first exposure. Unlike in the 0.6 mg/L group, where a down-
regulation tendency was observed at 2 weeks after first exposure, the 2.4 
mg/L group exhibited a striking upregulation of the genes in Cluster 1 the 
majority of which have known functions in cell autophagy, cell cyto-
skeleton, cell lysosome, cell stress, chemokine receptor and immune 
regulation, which may likely suggest recuperation from higher dose. 
Following re-exposure, both treatment groups demonstrated an identical 
branchial response after 2 weeks but not after 48 h of exposure in this 
gene cluster. Most of the DEGs that were substantially upregulated at this 
time point, particularly in the 0.6 mg/L group, were involved in the im-
mune response especially chemokines, cytokines and other key immune 
response effectors. The considerable representation of genes involved in 
branchial immune signalling indicates that PAA elicited a strong immu-
nological impact that likely initiated a series of immune responses as a 
protective mechanism at the gill mucosa. The degradation of PAA in the 
water results in the production of free radicals (Liu et al., 2020; Pedersen 
et al., 2009) and these radicals will eventually affect the oxidative state, 
triggering a cascade of immune effects to counter the physiological 
pressure (Biller and Takahashi, 2018; Srivastava and Pandey, 2015). The 
upregulation of these genes, especially those with immune regulatory 
functions, 2 weeks post-exposure may be related to establishing immu-
nological homeostasis following a substantial downregulation during the 
early hours of exposure. 
Fig. 1. External welfare status of Atlantic salmon exposed to therapeutic doses of peracetic acid. A) The overall external welfare index of each treatment group based 
on the average composite score of 11 external welfare indicators, as presented individually in panels B and C. 
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The second overly represented group is Cluster 4 with 171 DEGs 
(Fig. 2A), where 40 % of the DEGs are involved in cell apoptosis, cyto-
skeleton, folding and signalling, whereas a similar percentage play roles 
in mitochondrial metabolism, sugar and xenobiotic metabolism and 
protein biosynthesis (Fig. 2B). In this cluster, the patterns of expression 
in the two PAA-exposed groups were identical after the first exposure – 
upregulation 48 h and downregulation 2 weeks after exposure. More-
over, the magnitude of change was considerably larger in the 0.6 mg/L 
than in the 2.4 mg/L group, indicating that the scale of the PAA impacts 
on gill cellular signalling and metabolism are not entirely dependent on 
dose, though the patterns of regulation are similar. Responding to an 
environmental challenge (e.g., elevated ROS) carries a strong metabolic 
demand. Hence, the upregulation of these genes is likely important in 
mustering a robust and coordinated response to a stimulus, which is 
energy demanding. The two PAA-exposed groups exhibited opposing 
general profiles in this gene cluster after the re-exposure – upregulation 
for the 0.6 mg/L and downregulation for the 2.4 mg/L group at both 
sampling points. Genes that were remarkably upregulated in the 0.6 mg/ 
L group have key roles in cell protein folding and modification, cellular 
cytoskeleton, and tissue epithelium and glycan and, moreover, the 
magnitude of change increased at 2 weeks after re-exposure indicating 
that the impact may persist for some time. On the other hand, the 
changes in the 2.4 mg/L group were minimal in contrast to the 0.6 mg/L 
group following re-exposure. Whether this profile suggests tolerance or 
desensitisation to higher dose remains an open question. 
Mucosal transcriptomic profiling of the skin identified 671 DEGs – 
around 12.5 % higher than the gills (Fig. 3). Moreover, the overall 
changes in the cutaneous expression in the PAA-exposed groups were 
considerably larger in magnitude compared with the gills. The full list of 
DEGs is provided in Supplementary File 2. In terms of surface area to 
water contact ratio, the gills are larger than the skin (Koppang et al., 
2015). However, the results described here revealed that contact surface 
ratio did not entirely dictate the mucosal responses to PAA as the skin 
was identified as more responsive than the gills to the oxidant, at least in 
the concentration tested in the present trial. Though we could not fully 
ascertain as to why such a striking difference was observed, we speculate 
that this may be related to the prevalent cases of scale loss (Fig. 1) in 
both groups; it reduced the physical barrier thus rendering the outer 
layer of the epithelial surface a greater chance to come in contact with 
the oxidant. The DEGs can be further classified into 6 groups, with 
Clusters 1 (325 DEGs) and 3 (305) comprising the two most represented 
groups. In Cluster 1, the four annotation groups (cell: 24.9 %; immune: 
24.3 %; metabolism: 19.7 %; tissue: 31.1 %) were almost equally rep-
resented. Both PAA-exposed groups showed downregulation at 48 h 
Fig. 2. Gill transcriptome of Atlantic salmon exposed to therapeutic doses of peracetic acid. A) The heatmap on the left shows the down- and upregulation of DEGs in 
a colour gradient from blue to red. The dendrogram was split into seven sub-clusters and the mean values for genes within these clusters were represented in bar plots 
(error bars show +/- standard error of the mean) in the centre. B) Enrichment analyses of the seven sub-clusters. The identified functional gene categories are shown 
along the Y-axis and the six clusters along the X-axis. Dots were coloured according to the super categories (cell, immune, metabolism and tissue) and the size 
indicates the respective p-value level according to Fisher’s exact test. Sampling time notations: 1.48 h = 48 h after initial exposure; 1.2 w = 2 weeks after initial 
exposure; 2.48 h = 48 h after re-exposure; 2.2 w = 2 weeks after re-exposure. 
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after first exposure, with 0.6 mg/L group showing a relatively higher 
magnitude of response compared with the 2.4 mg/L group in this gene 
cluster. Some of the genes that were remarkably downregulated in both 
treatment groups are involved in immune lectin, lipid metabolism, 
protease metabolism and extracellular matrix. At the same time point 
after the re-exposure, an opposite trend was observed between groups in 
this cluster - downregulation was prominent in the 0.6 mg/L group while 
upregulation dominated the 2.4 mg/L group. The majority of the genes 
with marked downregulation in the 0.6 mg/L group were involved in 
acute immune response, antigen processing, complement, cytokines and 
immune effectors, which may likely suggest a transient immunosup-
pression. On the other hand, a significant portion of highly upregulated 
genes in the 2.4 mg/L group at this time point are involved in acute 
phase immune response, immune effector, immune lectin, and tissue 
secretion. Despite the contrasting profiles, the responses indicate inter-
ference of PAA on mucosal immunity. Both treatment groups displayed 
upregulation pattern in this gene cluster 2 weeks after the re-exposure 
where majority of substantially affected genes were crucial for immu-
nity and metabolism. It is also interesting to observe that the magnitude 
of change was higher at this timepoint than other timepoints within this 
gene cluster, which may be indicative of a cumulative effect or a 
chronic-latent response. The genes that were markedly affected in both 
treatments groups include those with a role in protein folding, acute 
phase immune response, immune lectin, protease metabolism, tissue 
extracellular matrix and tissue growth factor. The overall pattern with 
which the four groups of annotated genes were equally represented in 
the DEGs indicates that the cutaneous molecular repertoire was under 
tight regulatory control to maintain homeostasis in the skin following 
exposure to the oxidant. 
Cluster 3 is the second well-represented group in the DEGs in the skin 
(Fig. 3A). Around 40 % of the DEGs were annotated under metabolism 
while the rest of the genes fell within cell (~ 29 %), tissue (~ 20 %) and 
immune (~ 11.5 %) (Fig. 3B). This provides additional support for the 
foregoing observations that PAA exposure confers strong metabolic 
pressure on the mucosa, as this profile was also prominent in Cluster 4 in 
the gill transcriptome. Following the first exposure, Cluster 3 displayed 
upregulated expression regardless of the PAA dose and sampling time-
point. Some of the genes that were substantially upregulated at 48 h after 
first exposure in both groups have functions in cellular redox balance, 
mitochondrial metabolism, RNA metabolism and sugar metabolism. 
Fig. 3. Skin transcriptome of Atlantic salmon exposed to therapeutic doses of peracetic acid. Analysis and representation for DEGs of skin samples were conducted in 
the same way as for the gills. For further information, see the caption of Fig. 2. 
C.C. Lazado et al.                                                                                                                                                                                                                               
Aquatic Toxicology 227 (2020) 105625
7
Specifically, the upregulation of glutathione transferase Ω-1 and phospho-
glycerate kinase may be implicated to the control of the redox balance in 
the skin during the early phase post-exposure to the oxidant, since both 
genes are known to participate in this vital adaptive process when radi-
cals are in abundance (Kim et al., 2017; Tsukamoto et al., 2013). On the 
other hand, genes the are considerably upregulated in both treatment 
groups 2 weeks after the first exposure are involved in lectin-mediated 
immunity and xenobiotic metabolism. Interestingly, the magnitude of 
change at this timepoint was larger in the 0.6 mg/L group compared with 
the 2.4 mg/L group. Genes with an important role in proteolytic meta-
bolism were remarkably affected in the 0.6 mg/L group. The significantly 
elevated expression of proteolysis-related genes at this timepoint in-
dicates the potential involvement of heightened protein turnover as a 
recovery mechanism to oxidant treatment, which influences tissue 
structure and integrity during the early period after exposure. 
At 48 h after re-exposure, the genes in Cluster 3 were mostly upre-
gulated in the 0.6 mg/L group and downregulated in the 2.4 mg/L 
group. It appeared that cutaneous metabolic processes were remarkably 
affected in the 0.6 mg/L group as most upregulated genes were involved 
in RNA and mitochondrial metabolism. Downregulation was the hall-
mark response in the 2.4 mg/L group for this gene group at 48 h after the 
re-exposure. The trend of the impact, however, was not quite pro-
nounced compared with the 0.6 mg/L group. These profiles indicate that 
re-exposure may trigger a slight cutaneous metabolic disarray. Both 
groups exhibited downregulation profiles at 2 weeks after re-exposure, 
where the magnitude of response was more marked in the 0.6 mg/L 
than in the 2.4 mg/L group. The majority of the genes that were sub-
stantially downregulated in both groups are important in cell apoptosis, 
cell transcription, cell ubiquitination, immune regulation and mito-
chondrial metabolism. The downregulation in these genes may perhaps 
a form of compensation to counterbalance the substantial upregulation 
during first exposure. 
Overall, the impact on the mucosal transcriptome of the lower PAA 
dose (i.e., 0.6 mg/L) was more remarkable than the high dose (i.e., 2.4 
mg/L). The mucosa of the 0.6 mg/L-exposed group appears to exhibit 
substantial transcriptional changes, relatively robust responses based on 
the known function of identified DEGs and consistent response patterns. 
In overly represented gene clusters and in both mucosal tissues, a more 
marked response could be triggered 2 weeks after exposure, suggesting 
that there are numerous biological processes, particularly those 
involved in metabolism, that were activated for mucosal recovery and 
compensation. A cumulative effect is likely at play since dramatic 
changes in several gene clusters were often observed 2 weeks after the 
re-exposure, although, a chronic response is also possible for such a 
distinct profile. 
The core PAA-mucosal response genes in salmon are represented 
with 22 DEGs that are common in both skin and gill (Table 1). It is 
apparent that genes involved in immunity were not strikingly repre-
sented, at only around 13.6 % of the total DEGs in the core group. PAA 
triggered strong immunological responses in the mucosa, as shown by 
the individual transcriptome profiles where several immune-related 
genes were affected. However, it is likely that immune regulatory 
mechanisms in response to PAA in the two mucosal tissues may differ 
because the number of shared DEGs is low. This highlights the possibility 
that the crosstalk between mucosal immunity and oxidant-induced 
modulation is complex and both tissues may have different funda-
mental underlying pathways. Mucins are important glycoprotein com-
ponents of the mucus, an emblematic biological fluid covering mucosal 
surfaces. Mucin-2, in particular, is a common mucin in the intestinal 
mucosa, and only marginally expressed in the skin and gills of both naïve 
and stressed salmon (Sveen et al., 2017). Its regulation in response to 
PAA in both tissues reveals its essential role in maintaining mucosal 
glycopolymeric integrity and provides further insight into its functions 
beyond its well-established role in the gastrointestinal tract. Mucin-2 
expression was highest 2 weeks after the re-exposure in both mucosal 
tissues suggesting that it is important in the recovery of glycopolymeric 
Table 1 
List of differentially expressed genes that are identified both in the gills and skin of PAA-exposed salmon. An arrow indicates upregulation (↑) or downregulation (↓) 
relative to 0 mg/L. Each time point is represented with 2 arrows: the first arrow denotes the transcription in the gills while the second arrow was the expression in the 
skin.  
Annotation Gene Name 
0.6 mg/L 2.4 mg/L 

























Cell Apoptosis Baculoviral IAP repeat-containing 2 ↑↓ ↓↓ ↓↓ ↑↑ ↑↓ ↑↓ ↓↓ ↓↓ 
Cell Folding Serpin H1 (Hsp47) ↑↓ ↓↓ ↓↓ ↑↑ ↓↓ ↓↓ ↓↑ ↑↑ 
Cell GTP signaling Olfactomedin-4 ↑↓ ↓↓ ↓↓ ↑↑ ↓↑ ↓↑ ↓↑ ↑↑ 
Cell GTP signaling Rho GTPase-activating protein 33 ↑↓ ↓↑ ↓↓ ↑↑ ↓↓ ↓↓ ↑↑ ↑↑ 
Cell Myofiber Titin a - Ident 98 ↑↑ ↓↑ ↓↓ ↑↓ ↑↑ ↑↑ ↑↓ ↓↓ 
Cell Reticulum Protein transport protein Sec31A ↓↓ ↓↑ ↓↑ ↓↑ ↓↑ ↑↓ ↓↓ ↑↓ 
Cell Reticulum Reticulocalbin 3_ EF-hand calcium binding domain ↓↓ ↑↑ ↑↓ ↑↑ ↓↓ ↓↑ ↑↑ ↑↑ 
Immune Lectin Rhamnose-binding lectin WCL1 [Salvelinus leucomaenis] ↑↑ ↑↓ ↑↓ ↓↑ ↑↑ ↑↑ ↑↑ ↓↑ 
Immune macrophage ATP binding cassette G1 ↑↑ ↑↑ ↓↓ ↓↓ ↑↑ ↑↑ ↑↓ ↑↓ 
Immune T cell Rho GTPase-activating protein ↓↓ ↓↓ ↑↓ ↑↑ ↓↑ ↑↑ ↓↑ ↑↑ 
Metabolism Ion ATPase_ Na+/K + transporting_ beta 2b polypeptide ↓↓ ↑↑ ↓↓ ↓↑ ↓↓ ↑↑ ↑↑ ↑↑ 
Metabolism Lipid Lactosylceramide 1_3-N-acetyl-beta-D- 
glucosaminyltransferase A 
↑↑ ↓↑ ↓↑ ↓↓ ↓↑ ↑↓ ↑↓ ↓↓ 
Metabolism 
Mitochondria 
NADH-ubiquinone oxidoreductase chain 5 ↑↑ ↓↑ ↓↑ ↓↓ ↓↓ ↓↓ ↑↓ ↓↓ 
Metabolism Protease Carboxypeptidase E ↑↓ ↓↑ ↑↓ ↓↑ ↑↓ ↑↑ ↑↑ ↓↑ 
Metabolism Steroid, 
bile 
17 beta hydroxysteroid dehydrogenase 4 [Salmo trutta fario] ↑↓ ↓↑ ↓↑ ↑↓ ↓↑ ↓↓ ↑↑ ↓↓ 
Metabolism Sugar Glucosamine (UDP-N-acetyl)-2-epimerase/N- 
acetylmannosamine kinase 
↑↑ ↓↑ ↓↑ ↓↓ ↓↑ ↓↓ ↓↓ ↓↓ 
Tissue Adhesion Cadherin ↑↑ ↓↑ ↓↑ ↓↓ ↑↑ ↑↑ ↑↓ ↓↓ 
Tissue bone cartilage TNF receptor member 11B ↓↓ ↓↓ ↑↓ ↑↑ ↓↓ ↑↑ ↓↑ ↑↑ 
Tissue ECM Novel protein similar to vertebrate leprecan-like 1 (LEPREL1) ↓↓ ↑↑ ↑↓ ↓↑ ↓↓ ↓↑ ↑↑ ↓↑ 
Tissue ECM collagen Collagen I alpha 2 chain ↓↓ ↑↑ ↓↓ ↑↑ ↓↓ ↓↑ ↓↑ ↓↑ 
Tissue ECM mucus Mucin-2 ↓↓ ↓↓ ↑↓ ↑↑ ↓↓ ↑↑ ↓↑ ↑↑ 
Tissue ECM mucus Spondin 1a ↓↓ ↑↑ ↑↓ ↓↑ ↓↓ ↑↑ ↑↑ ↑↑  
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barrier mucosa after the treatments. Spondin 1a is also an epithelial 
mucus protein component (Lang et al., 2016) identified as significantly 
regulated by both treatments in both tissues. The shared regulatory 
profile between mucin-2 and spondin 1a suggests that they are probably 
the main molecular drivers of mucus biophysical barrier features in the 
PAA response. The genes identified here (Table 1) have not been 
described as involved in the antioxidant response in salmon, thus, the 
list provides potential markers for the mucosal oxidant response that 
should be verified and characterised in future studies. 
3.4. Presence of oxidant in the water does not trigger substantial disarray 
in the circulating metabolome, though metabolite-specific responses suggest 
key role in oxidative stress 
In a previously published paper, we demonstrated that the total 
plasma antioxidant capacity of salmon was significantly increased at 
varying degrees by PAA treatment (Soleng et al., 2019). We then asked 
whether an increased level of environmental ROS (in this case, PAA) 
would also elicit global systemic responses, such as in small molecule 
substrates, intermediates, and products of metabolism. A total of 39 
compounds (with authentic standards) were identified in the plasma 
(Table 2). The overall profile indicates that the exposure of salmon to 0.6 
and 2.4 mg/L PAA either for 5 or 30 min did not significantly alter the 
plasma metabolomes. This was supported by the PCA (Fig. 4A) and the 
loading (Fig. 4B) plots, which show an absence of significant groupings in 
the metabolomes in relation to the treatment group and sampling point. 
This indicates that the effects of PAA exposure were minimal and further 
suggests that the treatment did not trigger global metabolomic distur-
bances in salmon. Both treatments did not show clear distinction in their 
metabolomes unlike in their transcriptomic responses. This underscores 
the sensitivity of the mucosa to mount varying responses to different 
environmental pressures. As the first line of defence and the point of 
contact, the mucosa mustered a robust response to counteract physio-
logical PAA demands without leading to significant internal changes. 
We further scrutinised the individual metabolites to identify 
metabolite-specific responses to PAA treatments. There were 14 differen-
tially modulated metabolites, independent of PAA dose, duration and 
sampling time (Fig. 4C). Four of these were only affected at the low dose 
(0.6 mg/L) including valine, leucine, hexose and lysine. On the other hand, 
six metabolites were exclusively affected at the high dose (2.4 mg/L) and 
these were α-ketoglutaric acid, taurine, arginine, cytosine, pyridoxal and 
pyroglutamic acid. Five metabolites were identified as differentially 
modulated by the two PAA treatment groups including methionine, 
citrulline, histidine, tryptophan and trans-4-hydroxyproline. Looking at 
the loading plot (Fig. 4B), methionine and tryptophan behaved similarly 
while the other three compounds formed a separate cluster. All of these five 
metabolites have known functions in the mobilisation of the antioxidant 
response. 
Methionine (Fig. 4D) is likely a key molecule in the response of 
salmon to low doses of PAA, elevated 48 h after each treatment. 
Table 2 
List of identified metabolites in the plasma and their log2 ratio relative to the 0 mg/L group. Values that are underlined and in bold are metabolites significantly affected 
by PAA treatment. Positive values indicate increases while negative values denote decreases relative to 0 mg/L.  
Metabolite name 
0.6 mg/L 2.4 mg/L 
First exposure Re-exposure First exposure Re-exposure 
48 h 2 w 48 h 2 w 48 h 2 w 48 h 2 w 
Lactic acid − 0.40 − 0.19 − 0.03 − 0.09 − 0.21 − 0.20 − 0.26 − 0.12 
Valine 0.56 0.12 0.18 − 0.31 − 0.36 0.18 0.16 − 0.24 
Leucine 0.82 0.01 0.19 − 0.29 − 0.15 0.31 0.02 − 0.30 
Isoleucine 0.58 − 0.02 0.27 − 0.12 − 0.23 0.19 − 0.09 − 0.02 
Hypoxanthine − 0.52 − 1.06 0.29 − 0.23 0.41 − 0.30 − 0.38 − 0.66 
a-Ketoglutaric acid − 0.01 − 0.05 − 0.35 − 0.66 − 0.59 0.43 ¡0.46 − 0.14 
Methionine 0.80 − 0.34 0.48 0.32 0.73 0.34 − 0.11 0.00 
Tyrosine 0.25 − 0.06 0.20 − 0.33 − 0.27 0.22 − 0.25 − 0.07 
Taurine 0.50 − 0.30 0.06 − 0.23 0.74 − 0.17 − 0.27 − 0.27 
Citrulline 0.25 0.47 0.14 ¡0.63 − 0.29 0.50 0.46 − 0.26 
Hexose − 0.04 − 0.32 − 0.26 0.56 − 0.21 − 0.32 − 0.38 0.07 
Inosine − 0.22 − 0.70 0.03 − 0.03 0.09 − 0.02 − 0.60 − 0.23 
?3-hydroxybuturylcarnitine (C4) − 0.42 0.09 0.49 0.12 − 0.08 1.18 − 0.05 0.09 
?Succinylcarnitine (C4-DC) − 0.15 − 0.08 0.33 0.14 0.27 0.53 0.27 0.45 
4-aminobenzoic acid 0.13 − 0.08 0.57 0.37 0.14 − 0.05 0.27 0.35 
Acetylcarnitine (C2) − 0.08 − 0.19 0.53 − 0.02 0.09 0.94 0.14 0.06 
Adenine − 1.00 − 0.54 − 0.30 0.34 0.79 0.62 − 0.02 0.37 
Arginine 0.16 − 0.12 − 0.21 − 0.22 − 0.30 − 0.12 − 0.95 ¡0.91 
Carnitine 0.08 − 0.13 0.31 − 0.18 0.14 − 0.11 − 0.03 − 0.20 
Choline phosphate (PCHO) − 0.50 − 0.35 0.01 0.23 0.30 − 0.01 − 0.01 0.25 
Creatine 0.21 0.18 0.38 0.35 0.55 0.48 − 0.04 − 0.01 
Cyanocobalamin − 0.21 − 0.36 0.15 0.54 0.33 − 0.08 0.20 0.29 
Cytidine 0.02 − 0.41 − 0.11 − 0.29 − 0.07 − 0.34 − 0.04 − 0.44 
Cytosine − 0.41 0.28 0.11 0.14 − 0.41 0.50 0.94 0.09 
Glutamic acid − 0.43 − 0.23 0.03 0.35 0.13 − 0.20 − 0.13 0.19 
Guanosine − 0.26 − 0.45 0.01 0.02 − 0.17 0.06 − 0.19 − 0.13 
Histidine 0.39 0.49 − 0.02 − 0.63 − 0.13 0.22 0.16 ¡0.73 
Tryptophan 0.70 0.09 − 0.04 − 0.40 0.12 0.14 − 0.01 ¡0.34 
Lysine 1.10 − 0.39 − 0.06 − 0.45 0.06 0.54 − 0.18 − 0.43 
Nicotine amide 0.28 − 0.20 0.07 0.23 0.36 0.10 0.06 0.13 
Phenylalanine 0.15 − 0.18 − 0.05 − 0.14 − 0.11 − 0.12 − 0.15 − 0.11 
Propionylcarnitine (C3) 0.00 − 0.02 0.46 − 0.12 0.17 0.56 − 0.03 0.12 
Pyridoxal 0.24 0.24 0.16 − 0.73 − 0.46 0.37 0.17 ¡0.94 
Pyroglutamic acid − 0.06 0.09 0.12 0.08 0.02 0.04 − 0.17 0.33 
Serine 0.02 0.13 0.10 0.21 0.19 0.88 − 0.02 0.12 
Sorbitol/Mannitol − 0.41 − 0.08 − 0.02 0.19 − 0.43 − 0.27 0.15 0.14 
Threonine − 0.01 − 0.06 0.04 0.47 0.18 0.90 − 0.15 − 0.11 
Trans-4-hydroxyproline 0.33 0.77 0.10 − 0.19 0.43 0.54 0.63 − 0.03 
Uridine − 0.49 − 0.79 0.13 0.19 − 0.36 − 0.54 − 0.16 − 0.30  
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Methionine is an aliphatic, sulphur-containing, essential amino acid 
(Martínez et al., 2017) that has been identified as a crucial regulator of 
the oxidative state in fish (Coutinho et al., 2017). Methionine residues 
may act as catalytic antioxidants, methionine sulfoxide reductases in 
most cells, catalysing a thioredoxin-dependent reduction of methionine 
sulfoxide, which is formed when methionine react with ROS, back to 
methionine (Luo and Levine, 2009). The cyclic interconversion of the 
methionine residues in proteins between their oxidised and reduced 
forms may, therefore, be regarded as an efficient ROS-scavenging 
mechanism (Levine et al., 1999; Wu et al., 2012). It could be possible 
that the substantial increase in methionine at 48 h in both treatment 
occasions in the 0.6 mg/L group is an important early phase protective 
mechanism against increased environmental ROS and the trigger does 
not depend on the dose. 
For the 2.4 mg/L group, citrulline and histidine are the two mole-
cules that were identified as early phase responders with their level were 
substantially increased at 48 h after each exposure (Fig. 4D). It has been 
demonstrated in a mammalian model that L-citrulline can enhance nitric 
oxide bioavailability and concomitantly reduce oxidative stress, espe-
cially in the vascular epithelium (Dawoud and Malinski, 2020). On the 
other hand, the role of histidine in the mobilisation of the response to 
oxidative stress has been documented in fish, mainly through dietary 
interventions (Jiang et al., 2016; Yang et al., 2019). Previous knowledge 
of the potential involvement of these molecules during oxidative stress 
leads us to hypothesise that their increased circulatory level is likely a 
counter response to the pressures associated with increased levels of 
environmental radicals that affected the internal redox balance (Soleng 
et al., 2019). However, it remains unknown whether they act by scav-
enging or neutralising increased ROS. The markedly low levels of these 
molecules 2 weeks post-exposures suggest a probable compensatory 
response that stabilises their levels in the plasma. It is interesting to 
evaluate this marked downregulation at 2 weeks post-treatment in the 
future, particular their role in inflammatory activity because both 
molecules have known anti-inflammatory functions (Darabi et al., 2019; 
Watanabe et al., 2008) and some immune genes involved in this process 
(e.g., cytokines) were downregulated as well at the mucosa. 
Trans-4-hydroxyproline, an isomeric form of hydroxyproline, was 
significantly modulated both days and weeks after the initial and re- 
exposure in the 0.6 mg/L group (Fig. 4D). For the high dose, it was 
only markedly affected 48 h after treatments. This opposite response 
indicates that the trans-4-hydroxyproline-mediated response is not 
entirely dependent on the dose of PAA but may be dramatically influ-
enced by how the precursors (i.e., proline) is affected by PAA and 
eventually the impact on the synthesis of the metabolite. Hydroxypro-
line is a structurally and physiologically important amino acid in ani-
mals. Its conversion into glycine enhances the production of glutathione, 
and the oxidation of hydroxyproline by hydroxyproline oxidase plays 
essential parts in cell antioxidative reactions, survival and homeostasis 
(Wu et al., 2017). One may speculate that the increase in the 
PAA-exposed groups may be important for antioxidant defence, none-
theless, it has a crucial role in collagen synthesis (Amit Kumar et al., 
2016), which sheds light as to why PAA dramatically influenced the 
tissue extracellular matrix of the mucosa (Figs. 2 and 3). 
The pattern of tryptophan response was similar in both treatment 
groups 48 h after exposure regardless of the duration, where a marked 
elevation was observed (Fig. 4D). This response was no longer present 2 
weeks after exposure in the 0.6 mg/L group, however, the level was 
substantially reduced in the 2.4 mg/L group. The elevated level at the 
early phase after treatment can be attributed to the established antiox-
idant function of tryptophan. It is, together with some associated me-
tabolites (e.g., melatonin, kynurenic acid, and xanthurenic acid) act as 
effective antioxidants, removing reactive oxygen, reactive nitrogen, and 
Fig. 4. Plasma metabolome of Atlantic salmon exposed to therapeutic doses of peracetic acid. A) Score plot from the PCA model calculated from the relative 
concentrations of the variables in the identified compounds. Data are auto-scaled. B) Loading plot from the PCA model calculated from the relative concentrations of 
the variables in the identified compounds. Data are auto-scaled. C) Venn diagram showing metabolites that were differentially modulated by PAA. D) Changes in the 
5 metabolites that were differentially modulated in both treatment groups at least one timepoint. Values are expressed relative to the concentration in the 0 mg/L 
group at the same timepoint. Notations: 1.48 h = 48 h after initial exposure; 1.2 w = 2 weeks after first exposure; 2.48 h = 48 h after re-exposure; 2.2 w = 2 weeks 
after re-exposure. 
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active chlorine species and enhancing the organism’s protection against 
free radical damage (Xu et al., 2018). Tryptophan deficiency is related to 
several physiological problems that have severe implications on fish 
growth (Hoseini et al., 2019). Though our current data cannot support 
the probability that the remarkable downregulation of tryptophan at 2 
weeks post-treatments in the 2.4 mg/L group will lead to deficiency, it is 
logical to speculate that the decrease in plasma tryptophan level may not 
have been low enough to impair growth since both groups did not differ 
in weight after the trial. 
3.5. Conclusions 
Fish, in the wild and captivity, are constantly exposed to different 
environmental challenges that impact their health, fitness and survival. 
The use of strong oxidants, such as peroxides, are common in aquacul-
ture to improve water quality, rearing conditions and treating diseases, 
but how the host fish respond to these compounds is often overlooked. 
The results of the present study provide the first comprehensive evi-
dence for the global molecular responses that were mobilised in reaction 
to increased ROS levels in the rearing environment via the application of 
an oxidative chemotherapeutic PAA. Global transcriptomic profiles of 
the skin and gills of PAA-exposed fish identified the former as relatively 
more responsive to the tested treatment doses than the latter based on 
the magnitude of the transcriptional changes and the number of DEGs. 
The overall profiles further suggest that the mucosa could mount re-
sponses crucial to counteract the pressure of increased ROS levels. 
Moreover, plasma metabolome profiling showed that PAA treatments 
did not trigger metabolomic disturbances. Metabolite-specific re-
sponses, however, identified molecules with known functions during 
oxidative stress that were affected by PAA at both concentrations. The 
transcriptomic and metabolomic profiles corroborated the minimal 
impact of PAA on production performance parameters and external 
welfare indices. Therefore, PAA is a potential chemotherapeutic with 
minimal health and welfare impacts that salmon can physiologically 
adapt to. It is important to emphasise that the results presented here 
have to be considered as specific to the PAA product formulation and 
that we cannot rule out or guarantee that other product formulations 
(with different strengths, compositions and stabilisers) may lead to 
different responses, physiologically and behaviourally. 
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